Children under age 18: Semaglutide has not been studied in children so it is unknown whether it is effective and safe in young people
A recent study published in JAMA Network Open has drawn attention to a possible, though rare, side effect: optic nerve disorders , specifically a condition known as non-arteritic anterior ischemic optic neuropathy (NAION)
Those impressive clinical trial outcomes come from prescription medications that go directly into your bloodstream, not herbal supplements sitting on your skin
One-to-one coaching Sign up to access insurance-covered video calls to work with a glucose expert: a personal registered dietitian or certified nutritionist who will help tailor your lifestyle and diet to your goals
If you want a weight loss medication today, two FDA-approved options exist
For now, the tension between innovation and compliance remains a defining feature of the GLP-1 landscape